Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery

Acta Biomaterialia

Volumn 10, Issue 4, 2014, Pages 1705-1719

  Miller, Tobias ^a   Goude, Melissa C ^a   Mcdevitt, Todd C ^a   Temenoff, Johnna S ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Chemistry; Controlled release; Glycosaminolgycan; Growth factor; Protein binding

Indexed keywords

CHEMICAL MODIFICATION; DEGRADATION; MOLECULES; POLYELECTROLYTES; PROTEINS;

BIOMOLECULE DELIVERIES; CONTROLLED RELEASE; GLYCOSAMINOGLYCANS; GLYCOSAMINOLGYCAN; GROWTH FACTOR; MOLECULAR DELIVERY SYSTEM; MOLECULAR ENGINEERING; NEGATIVELY CHARGED; POSITIVELY CHARGED; PROTEIN-BINDING;

BIOCHEMISTRY;

CHONDROITIN SULFATE; DERMATAN SULFATE; GAG PROTEIN; GLYCOSAMINOGLYCAN; GROWTH FACTOR; HEPARAN SULFATE; HEPARIN; HYALURONIC ACID; KERATAN SULFATE; POLYELECTROLYTE;

ARTICLE; BIOCHEMISTRY; BIOLOGICAL ACTIVITY; CARBOHYDRATE ANALYSIS; CHEMICAL MODIFICATION; CONFORMATION; DRUG DELIVERY SYSTEM; ENZYMATIC DEGRADATION; GENETIC ENGINEERING AND GENE TECHNOLOGY; GLYCOSAMINOGLYCAN CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; REGENERATIVE MEDICINE; RING OPENING; STATIC ELECTRICITY; SULFATION;

CHEMISTRY; CONTROLLED RELEASE; GLYCOSAMINOLGYCAN; GROWTH FACTOR; PROTEIN BINDING;

ANIMALS; BIOENGINEERING; DRUG DELIVERY SYSTEMS; GLYCOSAMINOGLYCANS; HUMANS; PROTEIN BINDING;

EID: 84896390931     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.09.039     Document Type: Review

References (188)

1. R.V. Stick, and S. Williams Carbohydrates: The essential molecules of life 2010 Elsevier Science Oxford
2. E.D. Hay Extracellular matrix J Cell Biol 91 1981 205s 223s
3. L. Robert, and J. Labat-Robert Macromolecules of the extracellular matrix Ann Biol Clin 44 1986 145 151
4. L. Robert, A.M. Robert, and G. Renard Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging Pathol Biol 58 2010 187 198
5. J.E. Scott Structure and function in extracellular matrices depend on interactions between anionic glycosaminoglycans Pathol Biol (Paris) 49 2001 284 289
6. J.P. Urban, A. Maroudas, M.T. Bayliss, and J. Dillon Swelling pressures of proteoglycans at the concentrations found in cartilaginous tissues Biorheology 16 1979 447 464
7. J.D. Esko, K. Kimata, and U. Lindahl Proteoglycans and sulfated glycosaminoglycans A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, Essentials of glycobiology 2nd ed. 2009 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
8. A. Rapraeger, M. Jalkanen, E. Endo, J. Koda, and M. Bernfield The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans J Biol Chem 260 1985 11046 11052
9. J.P. Bali, H. Cousse, and E. Neuzil Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system Semin Arthritis Rheu 31 2001 58 68
10. C. Lallam-Laroye, Q. Escartin, A.S. Zlowodzki, D. Barritault, J.P. Caruelle, and B. Baroukh et al. Periodontitis destructions are restored by synthetic glycosaminoglycan mimetic J Biomed Mater Res A 79A 2006 675 683
11. L. Kock, C.C. van Donkelaar, and K. Ito Tissue engineering of functional articular cartilage: The current status Cell Tissue Res 347 2012 613 627
12. E.C. Huskisson Glucosamine and chondroitin for osteoarthritis J Int Med Res 36 2008 1161 1179
13. B. Casu, A. Naggi, and G. Torri Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans Semin Thromb Hemost Semin Thromb Hemost 28 2002 335 342
14. G. Kogan, L. Soltes, R. Stern, and P. Gemeiner Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications Biotechnol Lett 29 2007 17 25
15. N.S. Gandhi, and R.L. Mancera The structure of glycosaminoglycans and their interactions with proteins Chem Biol Drug Des 72 2008 455 482
16. N.S. Gandhi, and R.L. Mancera Prediction of heparin binding sites in bone morphogenetic proteins (BMPs) Biochim Biophys Acta Proteins Proteom 1824 2012 1374 1381
17. B.M. Sattelle, J. Shakeri, and A. Almond Does microsecond sugar ring flexing encode 3D-shape and bioactivity in the heparanome? Biomacromolecules 14 2013 1149 1159
18. E. Seyrek, and P. Dubin Glycosaminoglycans as polyelectrolytes Adv Colloid Interface 158 2010 119 129
19. I. Capila, and R.J. Linhardt Heparin-protein interactions Angew Chem Int Ed Engl 41 2002 390 412
20. A. Imberty, H. Lortat-Jacob, and S. Perez Structural view of glycosaminoglycan-protein interactions Carbohydr Res 342 2007 430 439
21. R.E. Hileman, J.R. Fromm, J.M. Weiler, and R.J. Linhardt Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins BioEssays 20 1998 156 167
22. T. Segura, B.C. Anderson, P.H. Chung, R.E. Webber, K.R. Shull, and L.D. Shea Crosslinked hyaluronic acid hydrogels: A strategy to functionalize and pattern Biomaterials 26 2005 359 371
23. O. Jeon, S.J. Song, K.J. Lee, M.H. Park, S.H. Lee, and S.K. Hahn et al. Mechanical properties and degradation behaviors of hyaluronic acid hydrogels cross-linked at various cross-linking densities Carbohydr Polym 70 2007 251 257
24. W.J. Kuo, M.A. Digman, and A.D. Lander Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization Mol Biol Cell 21 2010 4028 4041
25. M. Hook, L. Kjellen, S. Johansson, and J. Robinson Cell-surface glycosaminoglycans Annu Rev Biochem 53 1984 847 869
26. McNaught AD. Nomenclature of carbohydrates. In: Glycoscience. Berlin, Heidelberg: Springer-Verlag; 2008. p. 2727. ISBN 978-3-540-36154-1. http://dx.doi.org/10.1007/978-3-540-30429-6-70.
27. J.C. Boeyens The conformation of six-membered rings J Chem Crystallogr 8 1978 317 320
28. A. Fryer, Y.C. Huang, G. Rao, D. Jacoby, E. Mancilla, and R. Whorton et al. Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung J Pharmacol Exp Ther 282 1997 208 219
29. J. Hirsh, S.S. Anand, J.L. Halperin, and V. Fuster Mechanism of action and pharmacology of unfractionated heparin Arterioscl Throm Vas 21 2001 1094 1096
30. P. Vongchan, M. Warda, H. Toyoda, T. Toida, R.M. Marks, and R.J. Linhardt Structural characterization of human liver heparan sulfate Biochim Biophys Acta Gen Subj 1721 2005 1 8
31. S.M. Knox, and J.M. Whitelock Perlecan: How does one molecule do so many things? Cell Mol Life Sci 63 2006 2435 2445
32. A.J.A. Groffen, C.A.F. Buskens, T.H. van Kuppevelt, J.H. Veerkamp, L.A.H. Monnens, and L.P.W.J. van den Heuvel Primary structure and high expression of human agrin in basement membranes of adult lung and kidney Eur J Biochem 254 1998 123 128
33. T. Pap, and J. Bertrand Syndecans in cartilage breakdown and synovial inflammation Nat Rev Rheumatol 9 2013 43 55
34. H.B. Nader, S.F. Chavante, E.A. Dos-Santos, F.W. Oliveira, J.F. de-Paiva, and S.M.B. Jeronimo et al. Heparan sulfates and heparins: Similar compounds performing the same functions in vertebrates and invertebrates? Braz J Med Biol Res 32 1999 529 538
35. L.C.J. Yong The mast cell: Origin, morphology, distribution, and function Exp Toxicol Pathol 49 1997 409 424
36. C.L.R. Merry, M. Lyon, J.A. Deakin, J.J. Hopwood, and J.T. Gallagher Highly sensitive sequencing of the sulfated domains of heparan sulfate J Biol Chem 274 1999 18455 18462
37. M. Mobli, M. Nilsson, and A. Almond The structural plasticity of heparan sulfate NA-domains and hence their role in mediating multivalent interactions is confirmed by high-accuracy (15)N-NMR relaxation studies Glycoconjugate J 25 2008 401 414
38. R.A. Smith, K. Meade, C.E. Pickford, R.J. Holley, and C.L. Merry Glycosaminoglycans as regulators of stem cell differentiation Biochem Soc Trans 39 2011 383 387
39. R.J. Baldwin, G.B. ten Dam, T.H. van Kuppevelt, G. Lacaud, J.T. Gallagher, and V. Kouskoff et al. A developmentally regulated heparan sulfate epitope defines a subpopulation with increased blood potential during mesodermal differentiation Stem Cells 26 2008 3108 3118
40. J.T. Gallagher Heparan sulfate: Growth control with a restricted sequence menu J Clin Invest 108 2001 357 361
41. B. Mulloy, S. Khan, and S.J. Perkins Molecular architecture of heparin and heparan sulfate: Recent developments in solution structural studies Pure Appl Chem 84 2012 65 76
42. J.T. Gallagher, J.E. Turnbull, and M. Lyon Patterns of sulphation in heparan sulphate: Polymorphism based on a common structural theme Int J Biochem 24 1992 553 560
43. T. Barzu, J.C. Lormeau, M. Petitou, S. Michelson, and J. Choay Heparin-derived oligosaccharides: Affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells J Cell Physiol 140 1989 538 548
44. R. Xu, A. Ori, T.R. Rudd, K.A. Uniewicz, Y.A. Ahmed, and S.E. Guimond et al. Diversification of the structural determinants of fibroblast growth factor-heparin interactions: Implications for binding specificity J Biol Chem 287 2012 40061 40073
45. B.M. Loo, J. Kreuger, M. Jalkanen, U. Lindahl, and M. Salmivirta Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4 J Biol Chem 276 2001 16868 16876
46. M. Maccarana, B. Casu, and U. Lindahl Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor J Biol Chem 268 1993 23898 23905
47. S.M. Rickard, R.S. Mummery, B. Mulloy, and C.C. Rider The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: Importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRalpha1 Glycobiology 13 2003 419 426
48. S. Ricard-Blum, O. Feraud, H. Lortat-Jacob, A. Rencurosi, N. Fukai, and F. Dkhissi et al. Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: Role of divalent cations J Biol Chem 279 2004 2927 2936
49. M. Ishihara Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2 Glycobiology 4 1994 817 824
50. T. Spivak-Kroizman, M.A. Lemmon, I. Dikic, J.E. Ladbury, D. Pinchasi, and J. Huang et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation Cell 79 1994 1015 1024
51. H. Mori, Y. Kanemura, J. Onaya, M. Hara, J. Miyake, and M. Yamasaki et al. Effects of heparin and its 6-O- and 2-O-desulfated derivatives with low anticoagulant activity on proliferation of human neural stem/progenitor cells J Biosci Bioeng 100 2005 54 61
52. F.J. Moy, M. Safran, A.P. Seddon, D. Kitchen, P. Bohlen, and D. Aviezer et al. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor Biochemistry 36 1997 4782 4791
53. D.B. Volkin, P.K. Tsai, J.M. Dabora, J.O. Gress, C.J. Burke, and R.J. Linhardt et al. Physical stabilization of acidic fibroblast growth factor by polyanions Arch Biochem Biophys 300 1993 30 41
54. B.M. Sattelle, and A. Almond Less is more when simulating unsulfated glycosaminoglycan 3D-structure: Comparison of GLYCAM06/TIP3P, PM3-CARB1/TIP3P, and SCC-DFTB-D/TIP3P predictions with experiment J Comput Chem 31 2010 2932 2947
55. B.M. Sattelle, J. Shakeri, I.S. Roberts, and A. Almond A 3D-structural model of unsulfated chondroitin from high-field NMR: 4-sulfation has little effect on backbone conformation Carbohydr Res 345 2010 291 302
56. F. Yu, J.J. Wolff, I.J. Amster, and J.H. Prestegard Conformational preferences of chondroitin sulfate oligomers using partially oriented NMR spectroscopy of C-13-labeled acetyl groups J Am Chem Soc 129 2007 13288 13297
57. A.J. Herrera, M.T. Beneitez, L. Amorim, F.J. Canada, J. Jimenez-Barbero, and P. Sinay et al. Synthesis of a bicyclic analog of l-iduronic acid adopting the biologically relevant 2S0 conformation Carbohydr Res 342 2007 1876 1887
58. M. Hricovini, M. Guerrini, A. Bisio, G. Torri, A. Naggi, and B. Casu Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution Semin Thromb Hemost 28 2002 325 334
59. F.Y. Avci, N.A. Karst, and R.J. Linhardt Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties Curr Pharm Des 9 2003 2323 2335
60. S.K. Das, J.M. Mallet, J. Esnault, P.A. Driguez, P. Duchaussoy, and P. Sizun et al. Synthesis of conformationally locked l-iduronic acid derivatives: Direct evidence for a critical role of the skew-boat (2)S(0) conformer in the activation of antithrombin by heparin Chem Eur J 7 2001 4821 4834
61. S.K. Das, J.M. Mallet, J. Esnault, P.A. Driguez, P. Duchaussoy, and P. Sizun et al. Synthesis of conformationally locked carbohydrates: A skew-boat conformation of l-iduronic acid governs the antithrombotic activity of heparin Angew Chem Int Ed 40 2001 1670 1673
62. S. Guglier, M. Hricovini, R. Raman, L. Polito, G. Torri, and B. Casu et al. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy Biochemistry 47 2008 13862 13869
63. J.E. Scott, F. Heatley, and B. Wood Comparison of secondary structures in water of chondroitin-4-sulfate and dermatan sulfate - implications in the formation of tertiary structures Biochemistry 34 1995 15467 15474
64. A. Malmstrom, B. Bartolini, M.A. Thelin, B. Pacheco, and M. Maccarana Iduronic acid in chondroitin/dermatan sulfate: Biosynthesis and biological function J Histochem Cytochem 60 2012 916 925
65. A. Malmstrom Biosynthesis of dermatan sulphate. Loss of C-5 hydrogen during conversion of d-glucuronate to l-iduronate Biochem J 198 1981 669 675
66. L.Å. Fransson, F. Cheng, K. Yoshida, D. Heinegård, A. Malmström, and A. Schmidtchen Patterns of epimerization and sulphation in dermatan sulfate chains J.E. Scott, Dermatan sulfate proteoglycans: Chemistry, biology, chemical pathology 1993 The Biochemical Society London 11 25
67. C. Tanford, E. Marler, E.A. Davidson, and E. Jury Determination of molecular weight distribution of chondroitin sulfate B by sedimentation equilibrium J Biol Chem 239 1964 4034 4040
68. F. Dol, M. Petitou, J.C. Lormeau, J. Choay, C. Caranobe, and P. Sie et al. Pharmacologic properties of a low-molecular-weight dermatan sulfate - comparison with unfractionated dermatan sulfate J Lab Clin Med 115 1990 43 51
69. M. Kobayashi, G. Sugumaran, J.A. Liu, N.W. Shworak, J.E. Silbert, and R.D. Rosenberg Molecular cloning and characterization of a human uronyl 2-sulfotransferase that sulfates iduronyl and glucuronyl residues in dermatan chondroitin sulfate J Biol Chem 274 1999 10474 10480
70. C. Malavaki, S. Mizumoto, N. Karamanos, and K. Sugahara Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease Connect Tissue Res 49 2008 133 139
71. S. Yung, and T.M. Chan Glycosaminoglycans and proteoglycans: Overlooked entities? Perit Dial Int 27 Suppl 2 2007 S104 S109
72. S. Mizumoto, and K. Sugahara Glycosaminoglycans are functional ligands for receptor for advanced glycation end-products in tumors FEBS J 280 2013 2462 2470
73. F. Fernandez, J. Van Ryn, F.A. Ofosu, J. Hirsh, and M.R. Buchanan The haemorrhagic and antithrombotic effects of dermatan sulphate Br J Haematol 64 1986 309 317
74. P. Bendayan, H. Boccalon, D. Dupouy, and B. Boneu Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins Thromb Haemost 71 1994 576 580
75. F.A. Ofosu, G.J. Modi, M.A. Blajchman, M.R. Buchanan, and E.A. Johnson Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate Biochem J 248 1987 889 896
76. R.M. Maaroufi, P. Giordano, P. Triadou, J. Tapon-Bretaudiere, M.D. Dautzenberg, and A.M. Fischer Effect of oversulfated dermatan sulfate derivatives on platelet aggregation Thromb Res 120 2007 615 621
77. T.T. Hong, C.L. Van Gorp, A.D. Cardin, and B.R. Lucchesi Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury Thromb Res 117 2006 333 342
78. J.K. Hennan, T.T. Hong, A.K. Shergill, E.M. Driscoll, A.D. Cardin, and B.R. Lucchesi Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury J Pharmacol Exp Ther 301 2002 1151 1156
79. D. O'Keeffe, S.T. Olson, N. Gasiunas, J. Gallagher, T.P. Baglin, and J.A. Huntington The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism J Biol Chem 279 2004 50267 50273
80. T. Maruyama, T. Toida, T. Imanari, G. Yu, and R.J. Linhardt Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation Carbohydr Res 306 1998 35 43
81. C.I. Gama, S.E. Tully, N. Sotogaku, P.M. Clark, M. Rawat, and N. Vaidehi et al. Sulfation patterns of glycosaminoglycans encode molecular recognition and activity Nat Chem Biol 2 2006 467 473
82. A. Purushothaman, K. Sugahara, and A. Faissner Chondroitin sulfate wobble motifs modulate maintenance and differentiation of neural stem cells and their progeny J Biol Chem 287 2012 2935 2942
83. K. Sugahara, and T. Mikami Chondroitin/dermatan sulfate in the central nervous system Curr Opin Struct Biol 17 2007 536 545
84. J.M. Brown, J. Xia, B. Zhuang, K.S. Cho, C.J. Rogers, and C.I. Gama et al. A sulfated carbohydrate epitope inhibits axon regeneration after injury Proc Natl Acad Sci USA 109 2012 4768 4773
85. S.S. Deepa, Y. Umehara, S. Higashiyama, N. Itoh, and K. Sugahara Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors - implications as a physiological binding partner in the brain and other tissues J Biol Chem 277 2002 43707 43716
86. V. Hintze, A. Miron, S. Moeller, M. Schnabelrauch, H.P. Wiesmann, and H. Worch et al. Sulfated hyaluronan and chondroitin sulfate derivatives interact differently with human transforming growth factor-1 (TGF-1) Acta Biomater 8 2012 2144 2152
87. V. Hintze, S. Moeller, M. Schnabelrauch, S. Bierbaum, M. Viola, and H. Worch et al. Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4) Biomacromolecules 10 2009 3290 3297
88. D. Chen, M. Zhao, and G.R. Mundy Bone morphogenetic proteins Growth Factors 22 2004 233 241
89. N.D. Miljkovic, G.M. Cooper, and K.G. Marra Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells Osteoarthr Cartil 16 2008 1121 1130
90. T. Miyazaki, S. Miyauchi, A. Tawada, T. Anada, S. Matsuzaka, and O. Suzuki Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation J Cell Physiol 217 2008 769 777
91. S.F. Penc, B. Pomahac, T. Winkler, R.A. Dorschner, E. Eriksson, and M. Herndon et al. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function J Biol Chem 273 1998 28116 28121
92. A. Zamfir, D.G. Seidler, H. Kresse, and J. Peter-Katalinic Structural investigation of chondroitin/dermatan sulfate oligosaccharides from human skin fibroblast decorin Glycobiology 13 2003 733 742
93. K.R. Taylor, J.A. Rudisill, and R.L. Gallo Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity J Biol Chem 280 2005 5300 5306
94. K.A. Radek, K.R. Taylor, and R.L. Gallo FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation Wound Repair Regen 17 2009 118 126
95. T.N. Huckerby The keratan sulphates: Structural investigations using NMR spectroscopy Prog Nucl Mag Res Sp 40 2002 35 110
96. K. Meyer, A. Linker, E.A. Davidson, and B. Weissmann The mucopolysaccharides of bovine cornea J Biol Chem 205 1953 611 616
97. J.L. Funderburgh Keratan sulfate: Structure, biosynthesis, and function Glycobiology 10 2000 951 958
98. J.J. Hopwood, and H.C. Robinson Molecular-weight distribution of glycosaminoglycans Biochem J 135 1973 631 637
99. A.J. Quantock, R.D. Young, and T.O. Akama Structural and biochemical aspects of keratan sulphate in the cornea Cell Mol Life Sci 67 2010 891 906
100. E. Rodriguez, S.K. Roland, A. Plaas, and P.J. Roughley The glycosaminoglycan attachment regions of human aggrecan J Biol Chem 281 2006 18444 18450
101. N.B. Schwartz, M. Domowicz, R.C. Krueger, H. Li, and D. Mangoura Brain aggrecan Perspect Dev Neurobiol 3 1996 291
102. P.J. Roughley, L.I. Melching, T.F. Heathfield, R.H. Pearce, and J.S. Mort The structure and degradation of aggrecan in human intervertebral disc Eur Spine J 15 2006 S326 S332
103. T.N. Huckerby, G.H. Tai, and I.A. Nieduszynski Oligosaccharides derived by endo-beta-galactosidase digestion of bovine corneal keratan sulphate - characterisation of tetrasaccharides with incomplete sulphation and containing unsulphated N-acetylglucosamine residues Eur J Biochem 253 1998 499 506
104. Arnott S, Guss JM, Hukins DWL, Dea ICM, Rees DA. Conformation of keratan sulfate. J Mol Biol 1974;88:175.
105. J. Iwaki, T. Minamisawa, H. Tateno, J. Kominami, K. Suzuki, and N. Nishi et al. Desulfated galactosaminoglycans are potential ligands for galectins: Evidence from frontal affinity chromatography Biochem Bioph Res Commun 373 2008 206 212
106. R.C. Hughes Galectins as modulators of cell adhesion Biochimie 83 2001 667 676
107. B.P. Toole Hyaluronan: From extracellular glue to pericellular cue Nat Rev Cancer 4 2004 528 539
108. J. Dudhia Aggrecan, aging and assembly in articular cartilage Cellular Mol Life Sci 62 2005 2241 2256
109. A. Almond Hyaluronan Cell Mol Life Sci 64 2007 1591 1596
110. P. Pogany, and A. Kovacs Conformational properties of the disaccharide building units of hyaluronan Carbohydr Res 344 2009 1745 1752
111. J.Y. Lee, and A.P. Spicer Hyaluronan: A multifunctional, megaDalton, stealth molecule Curr Opin Cell Biol 12 2000 581 586
112. A. Aruffo, I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed Cd44 is the principal cell-surface receptor for hyaluronate Cell 61 1990 1303 1313
113. E.A. Turley, P.W. Noble, and L.Y.W. Bourguignon Signaling properties of hyaluronan receptors J Biol Chem 277 2002 4589 4592
114. J. Entwistle, C.L. Hall, and E.A. Turley Receptors: Regulators of signalling to the cytoskeleton J Cell Biochem 61 1996 569 577
115. R.J. Peach, D. Hollenbaugh, I. Stamenkovic, and A. Aruffo Identification of hyaluronic-acid binding-sites in the extracellular domain of Cd44 J Cell Biol 122 1993 257 264
116. S. Banerji, A.J. Wright, M. Noble, D.J. Mahoney, I.D. Campbell, and A.J. Day et al. Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction Nat Struct Mol Biol 14 2007 234 239
117. L. Lundin, H. Larsson, J. Kreuger, S. Kanda, U. Lindahl, and M. Salmivirta et al. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis J Biol Chem 275 2000 24653 24660
118. Z.L. Wu, L. Zhang, T. Yabe, B. Kuberan, D.L. Beeler, and A. Love et al. The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex J Biol Chem 278 2003 17121 17129
119. Y. Inoue, and K. Nagasawa Selective N-desulfation of heparin with dimethyl-sulfoxide containing water or methanol Carbohydr Res 46 1976 87 95
120. H. Baumann, M. Scheen, B. Huppertz, and R. Keller Novel regio- and stereoselective O-6-desulfation of the glucosamine moiety of heparin with N-methylpyrrolidinone-water or N,N-dimethylformamide-water mixtures Carbohydr Res 308 1998 381 388
121. K. Nagasawa, Y. Inoue, and T. Kamata Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl-sulfoxide containing water or methanol Carbohydr Res 58 1977 47 55
122. T. Toida, K. Sato, N. Sakamoto, S. Sakai, S. Hosoyama, and R.J. Linhardt Solvolytic depolymerization of chondroitin and dermatan sulfates Carbohydr Res 344 2009 888 893
123. K. Nagasawa, Y. Inoue, and T. Tokuyasu Improved method for the preparation of chondroitin by solvolytic desulfation of chondroitin sulfates J Biochem 86 1979 1323 1329
124. M. Jaseja, R.N. Rej, F. Sauriol, and A.S. Perlin Novel regioselective and stereoselective modifications of heparin in alkaline-solution - nuclear magnetic-resonance spectroscopic evidence Can J Chem 67 1989 1449 1456
125. T.G. Kantor, and M. Schubert A method for the desulfation of chondroitin sulfate J Am Chem Soc 79 1957 152 153
126. K. Nagasawa, H. Uchiyama, and N. Wajima Chemical sulfation of preparations of chondroitin 4-sulfate and 6-sulfate, and dermatan sulfate - preparation of chondroitin sulfate E-like materials from chondroitin 4-sulfate Carbohydr Res 158 1986 183 190
127. B.Z. Li, J. Suwan, J.G. Martin, F.M. Zhang, Z.Q. Zhang, and D. Hoppensteadt et al. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: New insights into adverse reactions from contaminated heparins Biochem Pharmacol 78 2009 292 300
128. A. Ogamo, A. Metori, H. Uchiyama, and K. Nagasawa Reactivity toward chemical sulfation of hydroxyl-groups of heparin Carbohydr Res 193 1989 165 172
129. Z. Wei, J.A. Deakin, B.S. Blaum, D. Uhrin, J.T. Gallagher, and M. Lyon Preparation of heparin/heparan sulfate oligosaccharides with internal N-unsubstituted glucosamine residues for functional studies Glycoconjugate J 28 2011 525 535
130. M.L. Purkerson, D.M. Tollefson, and S. Klahr N-desulfated acetylated heparin ameliorates the progression of renal-disease in rats with subtotal renal ablation J Clin Invest 81 1988 69 74
131. Diancourt F, Braud C, Vert M. Chemical modifications of heparin. 1. Reaction of partially N-desulfated heparin with glutaraldehyde. J Bioact Compat Pol 1994;9:267-81.
132. I.Y. Ponedel'kina, V.N. Odinokov, E.S. Lukina, T.V. Tyumkina, L.M. Khalilov, and U.M. Dzhemilev Chemical modification of heparin Russ J Bioorg Chem 32 2006 472 477
133. P.B. van Wachem, J.A. Plantinga, M.J.B. Wissink, R. Beernink, A.A. Poot, and G.H.M. Engbers et al. In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading J Biomed Mater Res 55 2001 368 378
134. M.J.B. Wissink, R. Beernink, J.S. Pieper, A.A. Poot, G.H.M. Engbers, and T. Beugeling et al. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation Biomaterials 22 2001 151 163
135. S.P. Seto, M.E. Casas, and J.S. Temenoff Differentiation of mesenchymal stem cells in heparin-containing hydrogels via coculture with osteoblasts Cell Tissue Res 347 2012 589 601
136. J.J. Lim, T.M. Hammoudi, A.M. Bratt-Leal, S.K. Hamilton, K.L. Kepple, and N.C. Bloodworth et al. Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery Acta Biomater 7 2011 986 995
137. M. Kim, Y. Shin, B.H. Hong, Y.J. Kim, J.S. Chun, and G. Tae et al. In vitro chondrocyte culture in a heparin-based hydrogel for cartilage regeneration Tissue Eng Part C Methods 16 2010 1 10
138. G. Tae, Y.J. Kim, W.I. Choi, M. Kim, P.S. Stayton, and A.S. Hoffman Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules Biomacromolecules 8 2007 1979 1986
139. V. Crescenzi, L. Cornelio, C. Di Meo, S. Nardecchia, and R. Lamanna Novel hydrogels via click chemistry: Synthesis and potential biomedical applications Biomacromolecules 8 2007 1844 1850
140. G. Testa, C. Di Meo, S. Nardecchia, D. Capitani, L. Mannina, and R. Lamanna et al. Influence of dialkyne structure on the properties of new click-gels based on hyaluronic acid Int J Pharm 378 2009 86 92
141. A.V. Reis, A.R. Fajardo, I.T.A. Schuquel, M.R. Guilherme, G.J. Vidotti, and A.F. Rubira et al. Reaction of glycidyl methacrylate at the hydroxyl and carboxylic groups of poly(vinyl alcohol) and poly(acrylic acid): Is this reaction mechanism still unclear? J Org Chem 74 2009 3750 3757
142. A.V. Reis, M.R. Guilherme, E.A.M.S. de Almeida, M.H. Kunita, E.C. Muniz, and A.F. Rubira et al. Copolymer hydrogel microspheres consisting of modified sulfate chondroitin-co-poly(N-isopropylacrylamide) J Appl Polym Sci 121 2011 2726 2733
143. Q. Li, C.G. Williams, D.D. Sun, J. Wang, K. Leong, and J.H. Elisseeff Photocrosslinkable polysaccharides based on chondroitin sulfate J Biomed Mater Res A 68 2004 28 33
144. T.R. Rudd, R.J. Nichols, and E.A. Yates Selective detection of protein secondary structural changes in solution protein-polysaccharide complexes using vibrational circular dichroism (VCD) J Am Chem Soc 130 2008 2138
145. A. Rullo, and M. Nitz Importance of the spatial display of charged residues in heparin-peptide interactions Biopolymers 93 2010 290 298
146. R.I.W. Osmond, W.C. Kett, S.E. Skett, and D.R. Coombe Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization Anal Biochem 310 2002 199 207
147. I. Danishefsky, and E. Siskovic Heparin derivatives prepared by modification of the uronic acid carboxyl groups Thromb Res 1 1972 173 181
148. D.S.W. Benoit, and K.S. Anseth Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation Acta Biomater 1 2005 461 470
149. L.R. Ruhaak, G. Zauner, C. Huhn, C. Bruggink, A.M. Deelder, and M. Wuhrer Glycan labeling strategies and their use in identification and quantification Anal Bioanal Chem 397 2010 3457 3481
150. J.F. Robyt Essentials of Carbohydrate Chemistry 1998 Springer Verlag New York
151. K.H. Bae, H. Mok, and T.G. Park Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death Biomaterials 29 2008 3376 3383
152. J. Liberda, M. Ticha, and V. Jonakova Preparation of fluorescein-labelled and biotinylated derivatives of polysaccharides for lectin-saccharide binding studies Biotechnol Tech 11 1997 265 267
153. H.P. Tan, C.R. Chu, K.A. Payne, and K.G. Marra Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering Biomaterials 30 2009 2499 2506
154. J.R. Glass, K.T. Dickerson, K. Stecker, and J.W. Polarek Characterization of a hyaluronic acid-Arg-Gly-Asp peptide cell attachment matrix Biomaterials 17 1996 1101 1108
155. J.S. Lee, D.H. Go, J.W. Bae, S.J. Lee, and K.D. Park Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor J Controlled Release 117 2007 204 209
156. O. Jeon, S.W. Kang, H.W. Lim, J. Hyung Chung, and B.S. Kim Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gel Biomaterials 27 2006 1598 1607
157. Y. Luo, K.R. Kirker, and G.D. Prestwich Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery J Controlled Release 69 2000 169 184
158. A.L. Chen, H.C. Ni, L.F. Wang, and J.S. Chen Biodegradable amphiphilic copolymers based on poly(epsilon-caprolactone)-graft chondroitin sulfate as drug carriers Biomacromolecules 9 2008 2447 2457
159. M. Jensen, P. Birch Hansen, S. Murdan, S. Frokjaer, and A.T. Florence Loading into and electro-stimulated release of peptides and proteins from chondroitin 4-sulphate hydrogels Eur J Pharm Sci 15 2002 139 148
160. A.M. Oprea, M.T. Nistor, M.I. Popa, C.E. Lupusoru, and C. Vasile In vitro and in vivo theophylline release from cellulose/chondroitin sulfate hydrogels Carbohydr Polym 90 2012 127 133
161. J.S. Lee, J.W. Bae, Y.K. Joung, S.J. Lee, D.K. Han, and K.D. Park Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle Int J Pharm 346 2008 57 63
162. S.C. Wang, B.H. Chen, L.F. Wang, and J.S. Chen Characterization of chondroitin sulfate and its interpenetrating polymer network hydrogels for sustained-drug release Int J Pharm 329 2007 103 109
163. K. Park, G.Y. Lee, Y.S. Kim, M. Yu, R.W. Park, and I.S. Kim et al. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity J Controlled Release 114 2006 300 306
164. H. Lyons, and J.A. Singer Effect of mucopolysaccharide linkage region and intrachain alkali labilities on chain weight determination J Biol Chem 246 1971 277 285
165. S. Hirano, M. Ishigami, and Y. Koga Depolymerization and de-N-acetylation of glycosaminoglycuronans by the action of alkali in the presence of sodium borohydride Connect Tissue Res 3 1975 73 79
166. J.E. Shively, and H.E. Conrad Formation of anhydrosugars in the chemical depolymerization of heparin Biochemistry 15 1976 3932 3942
167. M.J. Bienkowski, and H.E. Conrad Oligosaccharides formed by treatment of heparin with nitrous acid Semin Thromb Hemost 11 1985 86 88
168. M.J. Bienkowski, and H.E. Conrad Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid J Biol Chem 260 1985 356 365
169. 60Co gamma-irradiation on chondromucoprotein Int J Radiat Biol Relat Stud Phys Chem Med 32 1977 351 359
170. P.N. Shaklee, and H.E. Conrad Hydrazinolysis of heparin and other glycosaminoglycans Biochem J 217 1984 187 197
171. C.R. Roberts, J.S. Mort, and P.J. Roughley Treatment of cartilage proteoglycan aggregate with hydrogen peroxide. Relationship between observed degradation products and those that occur naturally during aging Biochem J 247 1987 349 357
172. O. Schmut, A.N. Ansari, and J. Faulborn Degradation of hyaluronate by the concerted action of ozone and sunlight Ophthalmic Res 26 1994 340 343
173. K. Nagasawa, H. Uchiyama, N. Sato, and A. Hatano Chemical change involved in the oxidative-reductive depolymerization of heparin Carbohydr Res 236 1992 165 180
174. O. Jeon, C. Powell, L.D. Solorio, M.D. Krebs, and E. Alsberg Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels J Controlled Release 154 2011 258 266
175. S.Y. Choh, D. Cross, and C. Wang Facile synthesis and characterization of disulfide-cross-linked hyaluronic acid hydrogels for protein delivery and cell encapsulation Biomacromolecules 12 2011 1126 1136
176. S. Ernst, R. Langer, C.L. Cooney, and R. Sasisekharan Enzymatic degradation of glycosaminoglycans Crit Rev Biochem Mol Biol 30 1995 387 444
177. B. Casu, and U. Lindahl Structure and biological interactions of heparin and heparan sulfate Adv Carbohydr Biochem 57 2001 159 206
178. R.J. Linhardt, P.M. Galliher, and C.L. Cooney Polysaccharide lyases Appl Biochem Biotech 12 1986 135 176
179. I. Vlodavsky, N. Ilan, A. Naggi, and B. Casu Heparanase: Structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate Curr Pharm Des 13 2007 2057 2073
180. J.R. Baker, and D.G. Pritchard Action pattern and substrate specificity of the hyaluronan lyase from group B streptococci Biochem J 348 2000 465 471
181. D.S. Pikas, J.P. Li, I. Vlodavsky, and U. Lindahl Substrate specificity of heparanases from human hepatoma and platelets J Biol Chem 273 1998 18770 18777
182. A. Naggi, B. Casu, M. Perez, G. Torri, G. Cassinelli, and S. Penco et al. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting J Biol Chem 280 2005 12103 12113
183. Z.P. Xiao, B.R. Tappen, M. Ly, W.J. Zhao, L.P. Canova, and H.S. Guan et al. Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin J Med Chem 54 2011 603 610
184. A. Nilasaroya, P.J. Martens, and J.M. Whitelock Enzymatic degradation of heparin-modified hydrogels and its effect on bioactivity Biomaterials 33 2012 5534 5540
185. M.V. Tsurkan, K. Chwalek, K.R. Levental, U. Freudenberg, and C. Werner Modular starPEG-heparin gels with bifunctional peptide linkers Macromol Rapid Commun 31 2010 1529 1533
186. C.C. Lin, and A.T. Metters Hydrogels in controlled release formulations: Network design and mathematical modeling Adv Drug Deliv Rev 58 2006 1379 1408
187. H.H. Chu, J. Gao, C.W. Chen, J. Huard, and Y.D. Wang Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis Proc Natl Acad Sci USA 108 2011 13444 13449
188. R.J. Parkinson, C.P. Demers, J.G. Adel, E.I. Levy, E. Sauvageau, and R.A. Hanel et al. Use of heparin-coated stents in neurovascular interventional procedures: Preliminary experience with 10 patients Neurosurgery 59 2006 812 821